Clinical Trials Directory

Trials / Completed

CompletedNCT01762189

The Incidence and Risk Factors of Neonatal Hyperbilirubinemia in Term and Late-preterm Chinese Infants

Multicenter Prospective Study on the Incidence and Risk Factors of Neonatal Hyperbilirubinemia in Term and Late-preterm Chinese Infants

Status
Completed
Phase
Study type
Observational
Enrollment
13,157 (actual)
Sponsor
Nanjing Medical University · Academic / Other
Sex
All
Age
1 Day – 28 Days
Healthy volunteers
Accepted

Summary

Thirteen hospitals in China will participate in the study, which aims to provide data on serum bilirubin levels in the first 168 hr after birth in term and late-preterm neonates, and estimate the incidence of severe neonatal hyperbilirubinemia and the underlying causes. We hypothesize that the study can be value in identifying and implementing strategies for risk reduction.

Detailed description

Neonatal hyperbilirubinemia resulting in clinical jaundice is a common problem among infants, particularly during the first weeks of life. Information about the incidence and risk factors of neonatal jaundice is not available from China where is one of the highest countries of the incidence of severe neonatal hyperbilirubinemia.

Conditions

Interventions

TypeNameDescription
PROCEDUREPhototherapyThe decision to use phototherapy conformed to the hour-specific threshold value for phototherapy presented by the American Academy of Pediatrics guidelines and was not at the discretion of the investigators.

Timeline

Start date
2013-01-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2013-01-07
Last updated
2014-10-28

Locations

14 sites across 1 country: China

Source: ClinicalTrials.gov record NCT01762189. Inclusion in this directory is not an endorsement.